A nurse is preparing to administer verapamil to a client who is 2 days postmyocardial infarction.
The nurse should monitor the client for which of the following outcomes as a therapeutic response to the medication?
Increased heart rate.
Increased blood pressure.
Decreased pulmonary congestion.
Decreased anginal pain.
The Correct Answer is D
Choice A rationale
Verapamil is a calcium channel blocker that typically reduces heart rate rather than increasing it by inhibiting calcium ion influx in the heart muscle, which decreases the heart's workload.
Choice B rationale
Verapamil generally lowers blood pressure by relaxing the smooth muscles in blood vessels, leading to vasodilation, not an increase in blood pressure.
Choice C rationale
Verapamil helps reduce pulmonary congestion by decreasing the workload on the heart, which can help alleviate symptoms of heart failure, but this is not the primary therapeutic effect in post-myocardial infarction patients.
Choice D rationale
Verapamil decreases anginal pain by relaxing coronary blood vessels, improving blood flow to the heart, and reducing myocardial oxygen demand, which is a primary therapeutic response.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
Acyclovir is an antiviral medication that inhibits viral DNA synthesis. It reduces the severity and duration of varicella-zoster virus symptoms by targeting the virus directly.
Choice B rationale
Vancomycin is an antibiotic effective against Gram-positive bacteria. It is not effective against viral infections like varicella-zoster, which requires antiviral treatment.
Choice C rationale
Gentamicin is an aminoglycoside antibiotic used to treat Gram-negative bacterial infections. It is ineffective against varicella-zoster virus, which is a viral infection.
Choice D rationale
Quinine is an antimalarial medication used to treat malaria. It does not have antiviral properties and is not effective against varicella-zoster virus.
Correct Answer is B
Explanation
Choice A rationale
Alosetron does not significantly impact gastric acid production. Its primary function is to modulate serotonin receptors in the gut, not to alter the secretion of gastric acids.
Choice B rationale
Alosetron, a serotonin receptor antagonist, is used to treat irritable bowel syndrome (IBS) by decreasing the frequency of defecation. It slows colonic transit time, reducing bowel movements.
Choice C rationale
Alosetron decreases gastric motility rather than increasing it. It works by slowing down the movements of the intestines, which helps to manage diarrhea-predominant IBS.
Choice D rationale
Alosetron's mechanism does not include increasing the absorption of water into the intestine. It primarily affects the neurotransmitters involved in bowel movement regulation.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
